Oxybutynin Chloride
Product Images NDC 10135-640
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10135-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers. (Oxybutynin Chloride Tablets 02)
Figure 2. Mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 To 15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybutynin Chloride Tablets 03)
Ndc 10135-0640-01marlexpharmaceuticals, Inc.oxybutyninchloride Tablets, Usp5 mgrx Only 100 Tablets (Oxybutynin Chloride Tablets 04)
This is a drug package label for Oxybutynin Chloride in tablet form with 100 tablets in a bottle. The tablets are for adult use only and there are dosage instructions provided. The drug is available only with a prescription. The label also includes manufacturer and distribution information. It is recommended to keep the medication away from children and store it in a USP-defined container that is tamper-resistant.*
Oxybutynin Chloride Tablets 05
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.